Michael A. Seidman

Michael A. Seidman

Auto-generated profile, based on publicly available information

Michael A. Seidman

Laboratory Medicine Program, University Health Network, Toronto, ON, Canada

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Genetics in Medicine
Verified
Journal Article
Closed access
TPTrevor J Pugh
Trevor J Pugh
MKMelissa A. Kelly
Melissa A. Kelly
SGSivakumar Gowrisankar
Sivakumar Gowrisankar
EHElizabeth Hynes
Elizabeth Hynes
MSMichael A. Seidman
Michael A. Seidman
BFBirgit H. Funke
Birgit H. Funke

27 March 2014 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
ASA S Savchenko
A S Savchenko
KMK Martinod
K Martinod
MSM A Seidman
M A Seidman
SWS L Wong
S L Wong
JBJ I Borissoff
J I Borissoff
DWDenisa Wagner
Denisa Wagner
Background A growing health problem, venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), requires refined diagnostic and therapeutic approaches. Neutrophils contribute to thrombus initiation and development in experimental DVT. Recent animal studies recognized neutrophil extracellular traps (NETs) as an important scaffold supporting thrombus stability. However, the hypothesis that human venous thrombi involve NETs has not undergone rigorous testing. Objective To explore the cellular composition and the presence of NETs within human venous thrombi at different stages of development. Patients and Methods We examined 16 thrombi obtained from 11 patients during surgery or at autopsy using histomorphological, immunohistochemical and immunofluorescence analyses. Results We classified thrombus regions as unorganized, organizing and organized according to their morphological characteristics. We then evaluated them, focusing on neutrophil and platelet deposition as well as micro‐vascularization of the thrombus body. We observed evidence of NET accumulation, including the presence of citrullinated histone H3 (H3Cit)‐positive cells. NETs, defined as extracellular diffuse H3Cit areas associated with myeloperoxidase and DNA, localized predominantly during the phase of organization in human venous thrombi. Conclusions NETs are present in organizing thrombi in patients with VTE. They are associated with thrombus maturation in humans. Dissolution of NETs might thus facilitate thrombolysis. This finding provides new insights into the clinical development and pathology of thrombosis and provides new perspectives for therapeutic advances.

26 November 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMichael A. Seidman
Michael A. Seidman
TOTitilope Oduyebo
Titilope Oduyebo
MMMichael G. Muto
Michael G. Muto
CCChristopher P. Crum
Christopher P. Crum
MNMarisa R. Nucci
Marisa R. Nucci
BQBradley J. Quade
Bradley J. Quade
Power morcellation has become a common technique for the minimally invasive resection of uterine leiomyomas. This technique is associated with dissemination of cellular material throughout the peritoneum. When morcellated uterine tumors are unexpectedly found to be leiomyosarcomas or tumors with atypical features (atypical leiomyoma, smooth muscle tumor of uncertain malignant potential), there may be significant clinical consequences. This study was undertaken to determine the frequency and clinical consequence of intraperitoneal dissemination of these neoplasms. From 2005–2010, 1091 instances of uterine morcellation were identified at BWH. Unexpected diagnoses of leiomyoma variants or atypical and malignant smooth muscle tumors occurred in 1.2% of cases using power morcellation for uterine masses clinically presumed to be “fibroids” over this period, including one endometrial stromal sarcoma (ESS), one cellular leiomyoma (CL), six atypical leiomyomas (AL), three smooth muscle tumor of uncertain malignant potential (STUMPs), and one leiomyosarcoma (LMS). The rate of unexpected sarcoma after the laparoscopic morcellation procedure was 0.09%, 9-fold higher than the rate currently quoted to patients during pre-procedure briefing, and this rate may increase over time as diagnostically challenging or under-sampled tumors manifest their biological potential. Furthermore, when examining follow-up laparoscopies, both from in-house and consultation cases, disseminated disease occurred in 64.3% of all tumors (zero of one ESS, one of one CL, zero of one AL, four of four STUMPs, and four of seven LMS). Only disseminated leiomyosarcoma, however, was associated with mortality. Procedures are proposed for pathologic evaluation of morcellation specimens and associated follow-up specimens. While additional study is warranted, these data suggest uterine morcellation carries a risk of disseminating unexpected malignancy with apparent associated increase in mortality much higher than appreciated currently.

25 September 2013 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
ALAdrienne V. Li
Adrienne V. Li
JMJames Moon
James Moon
WAWuhbet Abraham
Wuhbet Abraham
HSHeikyung Suh
Heikyung Suh
JEJamal Elkhader
Jamal Elkhader
DIDarrell J. Irvine
Darrell J. Irvine
A lipid nanocapsule vaccine promotes cross-presentation of antigen with enhanced draining lymph node delivery to elicit an effector memory CD8 + T cell response.

1 February 2014 in Gynecologic Oncology
Verified
Journal Article
Closed access
TOTitilope Oduyebo
Titilope Oduyebo
ARAlejandro J. Rauh-Hain
Alejandro J. Rauh-Hain
EMEmily E. Meserve
Emily E. Meserve
MSMichael A. Seidman
Michael A. Seidman
EHEmily Hinchcliff
Emily Hinchcliff
MMMichael G. Muto
Michael G. Muto

1 January 2016 in The American Journal of Pathology
Verified
Journal Article
Closed access
YSYue Shen
Yue Shen
FCFang Cheng
Fang Cheng
MSMehul Sharma
Mehul Sharma
YMYulia Merkulova
Yulia Merkulova
SRSheetal A. Raithatha
Sheetal A. Raithatha
DGDavid James Granville
David James Granville